BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25324198)

  • 41. Cost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 Years.
    Ladabaum U; Mannalithara A; Meester RGS; Gupta S; Schoen RE
    Gastroenterology; 2019 Jul; 157(1):137-148. PubMed ID: 30930021
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Formative Research on Knowledge and Preferences for Stool-based Tests compared to Colonoscopy: What Patients and Providers Think.
    Luque JS; Wallace K; Blankenship BF; Roos LG; Berger FG; LaPelle NR; Melvin CL
    J Community Health; 2018 Dec; 43(6):1085-1092. PubMed ID: 29767821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pioneering Annual Colorectal Cancer Screening and Treatment Targeting Low Income Communities in Malaysia (20102015).
    Tze CN; Fitzgerald H; Qureshi A; Tan HJ; Low ML
    Asian Pac J Cancer Prev; 2016; 17(7):3179-83. PubMed ID: 27509948
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cost-effectiveness of a patient navigation intervention to increase colonoscopy screening among low-income adults in New Hampshire.
    Rice K; Sharma K; Li C; Butterly L; Gersten J; DeGroff A
    Cancer; 2019 Feb; 125(4):601-609. PubMed ID: 30548480
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost Analysis of Free Colonoscopies in an Uninsured Population at Increased Risk for Colorectal Cancer.
    Sutton ER; Walling S; Kimbrough C; Borkhetaria N; Jones W; Sutton B
    J Am Coll Surg; 2016 Jul; 223(1):129-32. PubMed ID: 27238000
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and cost-effectiveness of fecal immunochemical test versus colonoscopy in colorectal cancer screening: a systematic review and meta-analysis.
    Zhong GC; Sun WP; Wan L; Hu JJ; Hao FB
    Gastrointest Endosc; 2020 Mar; 91(3):684-697.e15. PubMed ID: 31790657
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Should colorectal cancer screening start at different ages for men and women? Cost-effectiveness analysis for a resource-constrained service.
    Thomas C; Mandrik O; Whyte S; Saunders CL; Griffin SJ; Usher-Smith JA
    Cancer Rep (Hoboken); 2021 Aug; 4(4):e1344. PubMed ID: 33533190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical and Economic Impact of Tailoring Screening to Predicted Colorectal Cancer Risk: A Decision Analytic Modeling Study.
    Ladabaum U; Mannalithara A; Mitani A; Desai M
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):318-328. PubMed ID: 31796524
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The impact on clinical outcomes and healthcare resources from discontinuing colonoscopy surveillance subsequent to low-risk adenoma removal: A simulation study using the OncoSim-Colorectal model.
    Steer KJ; Sun Z; Sadowski DC; Yong JHE; Coldman A; Nemecek N; Yang H
    J Med Screen; 2024 Jun; 31(2):78-84. PubMed ID: 37728194
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-Effectiveness of Personalized Screening for Colorectal Cancer Based on Polygenic Risk and Family History.
    Cenin DR; Naber SK; de Weerdt AC; Jenkins MA; Preen DB; Ee HC; O'Leary PC; Lansdorp-Vogelaar I
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):10-21. PubMed ID: 31748260
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Results and cost-effectiveness of colorectal cancer screening program among urban residents in Zhejiang province, 2013-2018].
    Wang L; Li HZ; Zhu C; Wang YQ; Zhou HJ; Sun XH; Zhang MZ; Jin L; Du LB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Dec; 41(12):2080-2086. PubMed ID: 33378820
    [No Abstract]   [Full Text] [Related]  

  • 53. The multitarget fecal immunochemical test versus the fecal immunochemical test for programmatic colorectal cancer screening: a cross-sectional intervention study with paired design.
    Wisse PHA; de Klaver W; van Wifferen F; Meiqari L; Bierkens M; Greuter MJE; Carvalho B; van Leerdam ME; Spaander MCW; Dekker E; Coupé VMH; de Wit M; Meijer GA
    BMC Cancer; 2022 Dec; 22(1):1299. PubMed ID: 36503495
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Colonoscopy Versus Fecal Immunochemical Test for Reducing Colorectal Cancer Risk: A Population-Based Case-Control Study.
    Kim SY; Kim HS; Kim YT; Lee JK; Park HJ; Kim HM; Kang DR
    Clin Transl Gastroenterol; 2021 Apr; 12(5):e00350. PubMed ID: 33928919
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Colonoscopy vs. Fecal Immunochemical Test in Reducing Mortality From Colorectal Cancer (CONFIRM): Rationale for Study Design.
    Dominitz JA; Robertson DJ; Ahnen DJ; Allison JE; Antonelli M; Boardman KD; Ciarleglio M; Del Curto BJ; Huang GD; Imperiale TF; Larson MF; Lieberman D; O'Connor T; O'Leary TJ; Peduzzi P; Provenzale D; Shaukat A; Sultan S; Voorhees A; Wallace R; Guarino PD
    Am J Gastroenterol; 2017 Nov; 112(11):1736-1746. PubMed ID: 29016565
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Collaboration to increase colorectal cancer screening among low-income uninsured patients.
    Redwood D; Holman L; Zandman-Zeman S; Hunt T; Besh L; Katinszky W
    Prev Chronic Dis; 2011 May; 8(3):A69. PubMed ID: 21477509
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The impact of stratifying by family history in colorectal cancer screening programs.
    Goede SL; Rabeneck L; Lansdorp-Vogelaar I; Zauber AG; Paszat LF; Hoch JS; Yong JH; van Hees F; Tinmouth J; van Ballegooijen M
    Int J Cancer; 2015 Sep; 137(5):1119-27. PubMed ID: 25663135
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The comparative cost-effectiveness of colorectal cancer screening using faecal immunochemical test vs. colonoscopy.
    Wong MC; Ching JY; Chan VC; Sung JJ
    Sci Rep; 2015 Sep; 5():13568. PubMed ID: 26338314
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost-effectiveness of colorectal cancer screening in high-risk Spanish patients: use of a validated model to inform public policy.
    Ladabaum U; Ferrandez A; Lanas A
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2765-76. PubMed ID: 20810603
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Colorectal cancer screening for average-risk North Americans: an economic evaluation.
    Heitman SJ; Hilsden RJ; Au F; Dowden S; Manns BJ
    PLoS Med; 2010 Nov; 7(11):e1000370. PubMed ID: 21124887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.